Files
republic-os/legislation/us/states/de/150/hb-263.md
T
2026-07-06 17:26:56 -04:00

100 lines
4.8 KiB
Markdown
Raw Blame History

This file contains ambiguous Unicode characters
This file contains Unicode characters that might be confused with other characters. If you think that this is intentional, you can safely ignore this warning. Use the Escape button to reveal them.
---
type: "Bill"
title: "AN ACT TO AMEND TITLE 18 AND TITLE 29 OF THE DELAWARE CODE RELATING TO COST SHARING IN PRESCRIPTION INSULIN DRUGS."
description: "This Act requires that individual, group, and State employee insurance plans cap the amount an individual must pay for insulin prescriptions at $100 a month and must include at least 1 formulation of insulin on the lowest tier of the drug formulary developed and maintained by the carrier."
jurisdiction: "us/states/de"
legislature: "Delaware General Assembly"
session: "150"
identifier: "HB 263"
citation: "Delaware HB 263 (150)"
classification: ["bill"]
subjects: []
status: "enacted"
primary_sponsors: ["Andria L. Bennett", "Bryan Townsend", "Darius J. Brown", "David Bentz", "Melissa Minor-Brown", "Sherry Dorsey Walker"]
version_count: 2
action_count: 11
vote_count: 2
first_action: "2020-01-09"
last_action: "2020-07-16"
source: "openstates"
source_identifier: "ocd-bill/4b964ac8-1312-40b1-b210-31b0ec9388a4"
source_url: "https://legis.delaware.gov/BillDetail?LegislationId=47925"
source_hash: "d6ef57fed432618cd30a7b4287051a7455701ca1233b8939cde7f92efef8d8b0"
vintage: "2026-07-01"
source_snapshot: "https://data.openstates.org/daily/2026-07-01/public.pgdump"
retrieved_at: "2026-07-06"
confidence: "reported"
tags: ["legislation", "bill", "us-de"]
---
# Delaware HB 263 (150) — AN ACT TO AMEND TITLE 18 AND TITLE 29 OF THE DELAWARE CODE RELATING TO COST SHARING IN PRESCRIPTION INSULIN DRUGS.
This Act requires that individual, group, and State employee insurance plans cap the amount an individual must pay for insulin prescriptions at $100 a month and must include at least 1 formulation of insulin on the lowest tier of the drug formulary developed and maintained by the carrier.
## Version chain
The bill's text revisions, in order — the diff chain from filing to enrollment.
1. **Bill Text** (committee substitute) — [source](https://legis.delaware.gov/json/BillDetail/GenerateHtmlDocument?legislationId=47925&legislationTypeId=1&docTypeId=2&legislationName=HB263)
2. **HA 1 to HB 263** (committee substitute) — [source](http://legis.delaware.gov/json/BillDetail/GeneratePdfDocument?legislationId=48000&legislationTypeId=5&docTypeId=2)
## Votes
- SM — **210** (pass) · upper
- SM — **400** (pass) · lower
## Sponsors
- Andria L. Bennett — primary (person)
- Bryan Townsend — primary (person)
- Darius J. Brown — primary (person)
- David Bentz — primary (person)
- Melissa Minor-Brown — primary (person)
- Sherry Dorsey Walker — primary (person)
- David P. Sokola — cosponsor (person)
- Debra Heffernan — cosponsor (person)
- Earl G. Jaques Jr. — cosponsor (person)
- Edward S. Osienski — cosponsor (person)
- Ernesto B Lopez — cosponsor (person)
- Franklin D. Cooke — cosponsor (person)
- Gerald L. Brady — cosponsor (person)
- Harris B. McDowell — cosponsor (person)
- John "Jack" Walsh — cosponsor (person)
- John A. Kowalko — cosponsor (person)
- John J. Viola — cosponsor (person)
- John L. Mitchell — cosponsor (person)
- Kendra Johnson — cosponsor (person)
- Kimberly Williams — cosponsor (person)
- Krista Griffith — cosponsor (person)
- Laura V. Sturgeon — cosponsor (person)
- Michael F. Smith — cosponsor (person)
- Nnamdi O. Chukwuocha — cosponsor (person)
- Paul S. Baumbach — cosponsor (person)
- Raymond Seigfried — cosponsor (person)
- S. Elizabeth Lockman — cosponsor (person)
- Sean M. Lynn — cosponsor (person)
- Stephanie T. Bolden — cosponsor (person)
- Trey Paradee — cosponsor (person)
- Valerie Longhurst — cosponsor (person)
## Timeline
The legislative action history — every referral, reading, and vote.
- **2020-01-09** Introduced and Assigned to Health & Human Development Committee in House `introduction, referral-committee`
- **2020-01-15** Reported Out of Committee (Health & Human Development) in House with 5 Favorable, 4 On Its Merits `committee-passage-favorable, committee-passage`
- **2020-01-29** Amendment HA 1 to HB 263 - Introduced and Placed With Bill `amendment-introduction`
- **2020-01-29** Amendment HA 2 to HB 263 - Introduced and Placed With Bill `amendment-introduction`
- **2020-01-30** Amendment HA 1 to HB 263 - Passed In House by Voice Vote `amendment-passage`
- **2020-01-30** Amendment HA 2 to HB 263 - Stricken in House
- **2020-01-30** Passed By House. Votes: 40 YES 1 ABSENT `passage`
- **2020-02-28** Assigned to Health & Social Services Committee in Senate `introduction, referral-committee`
- **2020-06-16** Passed By Senate. Votes: 21 YES `passage`
- **2020-06-16** Suspension of Rules in Senate
- **2020-07-16** Signed by Governor `executive-signature`
## Source
OpenStates / OpenCivicData bulk snapshot [2026-07-01](https://data.openstates.org/daily/2026-07-01/public.pgdump); origin `ocd-bill/4b964ac8-1312-40b1-b210-31b0ec9388a4`. Confidence: reported (aggregated from official Delaware legislature records).